Shilpa Medicare receives USFDA approvals for Docetaxel injection
Shilpa Medicare has received final USFDA approval for Docetaxel Injection, used for treatment of various types of cancers. The company will market the inaction in […]
Month: May 2019
Natco Pharma receives USFDA approval for Nitroglycerin Sublingual Tablet
Natco Pharma has received final ANDA nod from USFDA for chest pain tablets through its marketing partner Alvogen. The drug Nitroglycerin Sublingual Tablets in strengths […]
Cipla receives USFDA approval for Ambrisentan
Cipla has received the final USFDA approval for the Abbreviated New Drug Application (ANDA) for their Ambrisentan Tablets, 5 mg and 10 mg. The drug […]
Lupin Pharma receives USFDA approval for Fluoxetine
Lupin Pharma has received USFDA approval for its Fluoxetine Tablets USP, 10 mg and 20 mg to market the same in US markets. The drug […]
Aurobindo Pharma plans expansion programme in Pydibhimavaram
Aurobindo Pharma is planning to expand its bulk drug unit in Pydibhimavaram/Chittivalasa in Ranasthalam Mandal in Srikakulam district of Andhra Pradesh. The project involves expanding […]
IOL Chemicals and Pharma plans expansion programme in Fategarh Channa
IOL Chemicals and Pharmaceuticals is planning to expand its production unit at Fategarh Channa in Mansa Road in Barnala Taluk in Sangrur district of Punjab. […]
Nebula Health Care plans expansion programme in Ankhol
Nebula Health Care is planning to expand its bulk drug unit in Ankhol village in Kadi Tehsil in Gandhinagar district of Gujarat. The project involves […]
Cadial receives USFDA approval for Chlorthalidone
Zydus Cadila has received final USFDA to market Chlorthalidone tablets, used to treat high blood pressure. The drug will be marketed in the strengths of […]
Glenmark Pharma receives USFDA approval for esomeprazole magnesium capsules
Glenmark Pharma has received final USFDA approval to market a generic version of AstraZeneca’s Nexium, used to treat acid reflux. The drug esomeprazole magnesium delayed-release […]